Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1458-1459 (28 June), doi:10.1136/bmj.326.7404.1458-c
| The first 150 words of the full text of this article appear below. |
EDITORChopdar et al's review of age related macular degeneration was timely,1 but they paid insufficient attention to the association between smoking and age related macular degeneration.
Pooled results from three large population based cross sectional studies found an odds ratio for all types of age related macular degeneration of 3.12 (95% confidence interval 2.10 to 4.64) for current smokers compared with never smokers.2 This increased risk was present for both atrophic age related macular degeneration and neovascular age related macular degeneration (odds ratios 2.54 (1.25 to 5.17) and 4.55 (2.74 to 7.54), respectively). Former smokers had only a slightly increased risk of age related macular degeneration compared with never smokers (odds ratio 1.36 (0.97 to 1.90)), which implies that stopping smoking may be an effective preventive approach.
Longer follow up further confirms the link between smoking and age related
macular degeneration.3
4 The Australian Blue
Mountains eye study also
C Simon P Kelly, consultant ophthalmic surgeon
Bolton Hospitals NHS Trust, Bolton BL4 OJR Simon.Kelly@boltonh-tr.nwest.nhs.uk
Richard Edwards, senior lecturer in public health medicine
Evidence for Population Health Unit, School of Epidemiology and Health Sciences, The Medical School, University of Manchester, Manchester M13 9PT
Peter Elton, director of public health
Bury Primary Care NHS Trust, Bury BL9 0EN
Paul Mitchell, professor of clinical ophthalmology
University of Sydney, Department of Ophthalmology Centre for Vision Research, Westmead Hospital, Westmead, NSW 2145, Australia